Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes

Pek Yee Lum(Merck & Co., Inc., Rahway, NJ, USA (United States)), Christopher D. Armour(Merck & Co., Inc., Rahway, NJ, USA (United States)), S. Stepaniants(Merck & Co., Inc., Rahway, NJ, USA (United States)), Guy Cavet(Merck & Co., Inc., Rahway, NJ, USA (United States)), Maria K. Wolf(University of Rochester), J. Scott Butler(University of Rochester), Jerald C. Hinshaw(University of Utah), Philippe Garnier(University of Utah), Glenn D. Prestwich(University of Utah), Amy Leonardson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Philip W. Garrett-Engele(Merck & Co., Inc., Rahway, NJ, USA (United States)), Christopher M. Rush(University of Indianapolis), Martin Bard(University of Indianapolis), Greg Schimmack(Merck & Co., Inc., Rahway, NJ, USA (United States)), John W. Phillips(Merck & Co., Inc., Rahway, NJ, USA (United States)), CJ Roberts(Merck & Co., Inc., Rahway, NJ, USA (United States)), Daniel Shoemaker(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cell
January 1, 2004
10.1016/s0092-8674(03)01035-3
Cited by 485Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis